Gene Therapy Clinical Trials
Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia
This research trial studies the shotgun sequencing of blood samples in diagnosing febrile neutropenia in patients with acute myeloid leukemia. Studying samples of blood from patients with acute myeloid leukemia in the laboratory may help identify pathogens and accurately diagnose infections such as febrile neutropenia.
Stanford is currently not accepting patients for this trial.
Intervention(s):
- other: Cytology Specimen Collection Procedure
- other: Laboratory Biomarker Analysis
Eligibility
Inclusion Criteria:
- Patients with febrile neutropenia
- A primary diagnosis of acute myeloid leukemia (AML)
Exclusion Criteria:
- Prior history of febrile neutropenia
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Stanley Deresinski
Not Recruiting